Related Experiment Video
Updated: Jun 3, 2026
11:49
Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
Published on: April 3, 2026
Laparoendoscopic single-site extraperitoneal aortic lymphadenectomy: first experience
Samer Schuman1, Joseph A Lucci, Leo B Twiggs
1Division of Gynecologic Oncology, Sylvester Comprehensive Cancer Center, University of Mami-Miller School of Medicine, Miami, Florida, USA. sschuman@med.miami.edu
Summary
This study demonstrates the feasibility and safety of laparoendoscopic single-site (LESS) extraperitoneal aortic lymphadenectomy for cervical cancer staging. The procedure yielded comprehensive lymph node assessment, enabling tailored radiation therapy for improved patient outcomes.
Area of Science:
- Minimally Invasive Surgery
- Surgical Oncology
- Gynecologic Oncology
Background:
- Advanced cervical cancer requires accurate staging, including assessment of paraaortic lymph nodes.
- Traditional surgical approaches for aortic lymphadenectomy can be invasive.
Observation:
- A novel laparoendoscopic single-site (LESS) extraperitoneal aortic lymphadenectomy was performed in a patient with locally advanced cervical cancer.
- The procedure utilized a single small incision and specialized laparoscopic instruments.
Findings:
- The LESS extraperitoneal aortic lymphadenectomy was completed successfully within 125 minutes with minimal blood loss and no complications.
- Ten lymph nodes were retrieved, with one containing metastatic squamous cell carcinoma, confirming the procedure's oncologic efficacy.
- The patient was discharged on postoperative day 1.
Implications:
- LESS extraperitoneal aortic lymphadenectomy is a feasible and safe approach for comprehensive aortic lymph node assessment in cervical cancer.
- This minimally invasive technique allows for precise oncologic staging and facilitates personalized treatment planning, including radiation therapy.
- The findings support the adoption of LESS techniques in gynecologic oncology for improved patient recovery and oncologic control.
